<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20210416050988N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-05-24</date_registration>
      <primary_sponsor>Faculty of Medical Sciences, Tarbiat Modares University</primary_sponsor>
      <public_title>Investigating the Effect of Educational Intervention Based on Health Belief Model on COVID-19 Preventive Behaviors among teachers</public_title>
      <acronym></acronym>
      <scientific_title>Design, Implementation and Evaluation of an Educational Intervention Based on Health Belief Model in COVID-19 Preventive Behaviors among teachers</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-04-26</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>140</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/55671</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Education/Guidance, Randomization description: We write the names of all education districts of Karaj (4 districts) on paper and put them in a bag. Select the area that comes out of the bag first as the intervention area and the area that comes out the second as the control area. We assign code to all schools in these two areas. We put the relevant codes in a bag and extract 10 codes from each area. The teachers of these 20 schools will be evaluated in terms of inclusion and non-inclusion criteria, and those who meet the required criteria will complete the pre-test, Blinding description: In this study, the researcher, participants in the research and data analyzers do not know the names of individuals. Participants in the study will be identified based on the code and no personal information will be collected from the individuals in the study.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Coronavirus 2019 (Covid-19).</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: The intervention group will be trained in Covid-19 preventive behaviors for one month. These trainings will be in the form of holding online meetings and website-based training and daily training through virtual networks. Educational contents in the form of motion graphics, infographics, posters, booklets and stickers will be provided to the members of the intervention group. In this way, after completing the pre-test, the intervention group becomes a member of a group and little by little content is sent to them on a daily basis. During these four weeks, an online training session is held weekly to transfer and explain the content and group discussion. The address of the designed site is also provided to the intervention group and they can refer to it at any time and place and use its contents. Intervention 2: Control group:  Not providing preventive behavioral training from Covid-19.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Data on major outcomes can be shared.

When:
Access period starts 6 months after the results are published

To whom:
The data will be available only to researchers working in academic and scientific institutions

Conditions:
Frequent measurement analysis to evaluate the duration of training 6 months after the last intervention

Where to obtain:
Via the email address of Dr. Farkhondeh Amin Shokravi aminsh_f@modares.ac.ir

How to obtain:
One week after sending the e-mail, the applicant will respond to the e-mail address of Dr. Farkhondeh Amin Shokravi.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Farkhondeh Amin Shokravi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Medical Sciences, Tarbiat Modares University, Jalal Al-Ahmad HWY., Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1411713116</zip>
        <telephone>+98 21 8288 4506</telephone>
        <email>aminsh_f@modares.ac.ir</email>
        <affiliation>Tarbiat Modares University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Farkhondeh Amin Shokravi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Medical Sciences, Tarbiat Modares University, Jalal Al-Ahmad HWY., Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1411713116</zip>
        <telephone>+98 21 8288 4506</telephone>
        <email>aminsh_f@modares.ac.ir</email>
        <affiliation>Tarbiat Modares University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Teachers working in Karajprimary schools
Having a smart phone and the ability to use it
Living in Karaj city</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>70 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>history of Covid-19 infection</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>u07.1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>U07.1: COVID-19, Virus identified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: The intervention group will be trained in Covid-19 preventive behaviors for one month. These trainings will be in the form of holding online meetings and website-based training and daily training through virtual networks. Educational contents in the form of motion graphics, infographics, posters, booklets and stickers will be provided to the members of the intervention group. In this way, after completing the pre-test, the intervention group becomes a member of a group and little by little content is sent to them on a daily basis. During these four weeks, an online training session is held weekly to transfer and explain the content and group discussion. The address of the designed site is also provided to the intervention group and they can refer to it at any time and place and use its contents.</i_keyword>
      <i_keyword>Control group:  Not providing preventive behavioral training from Covid-19</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The mean score of knowledge about Quid-19 in the questionnaire was achieved. Timepoint: At the beginning of the study (before the intervention) and immediately, one and three months after the end of the intervention. Method of measurement: researcher-made Corona questionnaire.</prim_outcome>
      <prim_outcome>The mean perceived susceptibility score about Quid-19 in the researcher-made questionnaire. Timepoint: At the beginning of the study (before the intervention) and immediately, one and three months after the end of the intervention. Method of measurement: researcher-made Corona questionnaire.</prim_outcome>
      <prim_outcome>The mean perceived severity score about Quid-19 in the researcher-made questionnaire. Timepoint: At the beginning of the study (before the intervention) and immediately, one and three months after the end of the intervention. Method of measurement: researcher-made Corona questionnaire.</prim_outcome>
      <prim_outcome>The mean perceived benefits score about Quid-19 in the researcher-made questionnaire. Timepoint: At the beginning of the study (before the intervention) and immediately, one and three months after the end of the intervention. Method of measurement: researcher-made Corona questionnaire.</prim_outcome>
      <prim_outcome>The mean perceived barriers score about Quid-19 in the researcher-made questionnaire. Timepoint: At the beginning of the study (before the intervention) and immediately, one and three months after the end of the intervention. Method of measurement: researcher-made Corona questionnaire.</prim_outcome>
      <prim_outcome>The mean cues to action score about Quid-19 in the researcher-made questionnaire. Timepoint: At the beginning of the study (before the intervention) and immediately, one and three months after the end of the intervention. Method of measurement: researcher-made Corona questionnaire.</prim_outcome>
      <prim_outcome>The mean self efficacy score about Quid-19 in the researcher-made questionnaire. Timepoint: At the beginning of the study (before the intervention) and immediately, one and three months after the end of the intervention. Method of measurement: researcher-made Corona questionnaire.</prim_outcome>
      <prim_outcome>The mean score of preventive behaviors of Covid-19 in the researcher-made questionnaire. Timepoint: At the beginning of the study (before the intervention) and immediately, one and three months after the end of the intervention. Method of measurement: researcher-made Corona questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Faculty of Medical Sciences, Tarbiat Modares University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-01-24</approval_date>
        <contact_name>Ethics committee of Tarbiat Modares University</contact_name>
        <contact_address>Jalal Al-Ahmad HWY Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
